Evidence for non-covalent clusters of the c-met proto-oncogene product
- PMID: 1317541
Evidence for non-covalent clusters of the c-met proto-oncogene product
Abstract
The met proto-oncogene is a member of the tyrosine kinase growth factor receptor family and is the receptor for hepatocyte growth factor (HGF) or scatter factor. The primary met product is a 150 kDa precursor that is glycosylated to generate a 170 kDa (p170met) proreceptor protein. The mature form of the receptor is generated by cleavage of p170met to yield a disulfide-linked 140 kDa beta-subunit (p140met) and a 45 kDa alpha-subunit (p45met). Both products are glycosylated. Under non-reducing conditions both p170met and the alpha, beta-disulfide-linked protein are detected as a 185 kDa product (p185met), but only alpha-beta heterodimeric p185met is cross-linked and rendered resistant to disulfide reduction with membrane-impermeable 6.4 A linker length cross-linking reagents. These data indicate that the p170 precursor is not on the cell surface. Cross-linking experiments using 12-A linker reagents yield multimeric forms of alpha-beta heterodimeric p185met greater than 500 kDa in size. These multimeric forms are produced in all cell lines tested regardless of the levels of protein expressed. These data suggest that alpha-beta heterodimeric p185met occurs in clusters or patches on the cell surface. Immunohistochemical analysis of met protein in the absence of ligand reveals a clustered staining pattern on the cell surface.
Similar articles
-
Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells.EXS. 1993;65:131-65. EXS. 1993. PMID: 8380735 Review.
-
Biosynthesis of the protein encoded by the c-met proto-oncogene.Oncogene. 1989 Nov;4(11):1383-8. Oncogene. 1989. PMID: 2554238
-
The hepatocyte growth factor and its receptor.Stem Cells. 1993 Jul;11 Suppl 2:22-30. doi: 10.1002/stem.5530110805. Stem Cells. 1993. PMID: 8401259 Review.
-
[Analysis of the hepatocyte growth factor receptor in regeneration and oncogenesis of hepatocytes].Hokkaido Igaku Zasshi. 1994 Mar;69(2):301-11. Hokkaido Igaku Zasshi. 1994. PMID: 8157255 Japanese.
-
Isoforms of the met receptor tyrosine kinase.EXS. 1993;65:167-79. EXS. 1993. PMID: 8380736 Review.
Cited by
-
Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway.Mol Cell Biol. 1997 Feb;17(2):799-808. doi: 10.1128/MCB.17.2.799. Mol Cell Biol. 1997. PMID: 9001234 Free PMC article.
-
Hepatocyte Growth Factor Isoforms in Tissue Repair, Cancer, and Fibrotic Remodeling.Biomedicines. 2014 Nov 5;2(4):301-326. doi: 10.3390/biomedicines2040301. Biomedicines. 2014. PMID: 28548073 Free PMC article. Review.
-
Dysregulation of Met receptor tyrosine kinase activity in invasive tumors.J Clin Invest. 2002 Apr;109(7):863-7. doi: 10.1172/JCI15418. J Clin Invest. 2002. PMID: 11927612 Free PMC article. Review. No abstract available.
-
Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer.J Carcinog. 2008;7:9. doi: 10.4103/1477-3163.44372. J Carcinog. 2008. PMID: 19240370 Free PMC article.
-
Activated c-Met signals through PI3K with dramatic effects on cytoskeletal functions in small cell lung cancer.J Cell Mol Med. 2002 Oct-Dec;6(4):539-53. doi: 10.1111/j.1582-4934.2002.tb00453.x. J Cell Mol Med. 2002. PMID: 12611639 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Miscellaneous